Nurtec Alternatives for Migraine Relief

Nurtec ODT is a prescription calcitonin gene-related peptide (CGRP) receptor antagonist used for the acute treatment of migraine and the preventive treatment of episodic migraine in adults. Some people compare alternatives because they want a drug-free option, a different treatment format, fewer medication-related considerations, or a treatment that fits more easily into their migraine routine.

Alternatives to Nurtec include FDA-cleared neuromodulation devices, other CGRP-targeting medications, triptans, over-the-counter pain relievers, and non-pharmaceutical strategies. These options differ in treatment purpose, prescription requirements, mechanism, age indication, cost structure, side effects, and practical use.

Cefaly ranks first in this guide because it combines prescription-free access, drug-free external trigeminal nerve stimulation, Acute and Prevent programs in one reusable device, and Cefaly-specific evidence from sham-controlled clinical studies. This ranking reflects accessibility, treatment scope, and practical features rather than an unsupported head-to-head claim of clinical superiority.

Key Takeaways

• Cefaly provides acute and preventive treatment: Cefaly is an FDA-cleared, prescription-free external trigeminal nerve stimulation device for acute and preventive migraine treatment in adults.
• Cefaly avoids systemic drug exposure: Because it is drug-free, Cefaly does not involve drug metabolism or drug-drug interactions. It can still cause device-related effects, which are generally minor and reversible.
• Nurtec and Cefaly work differently: Nurtec is an oral CGRP receptor antagonist, while Cefaly delivers electrical stimulation through an electrode placed on the forehead.
• Other medication options remain available: Other gepants, CGRP monoclonal antibodies, triptans, and over-the-counter medications have different indications, formulations, and safety considerations.
• Lifestyle strategies are supportive, not interchangeable: Sleep regularity, hydration, meal timing, trigger awareness, behavioral therapy, and sensory-reduction measures may support migraine management but do not replace an indicated acute or preventive treatment.

Understanding Nurtec and Why People Compare Alternatives

Nurtec ODT prescribing information lists two adult indications:

• Acute treatment of migraine with or without aura
• Preventive treatment of episodic migraine

Nurtec is taken as a 75 mg orally disintegrating tablet. The current U.S. label states that acute dosing is taken as needed, while preventive dosing is taken every other day. It also includes warnings and precautions involving hypersensitivity reactions, hypertension, Raynaud’s phenomenon, and certain drug interactions.

Common reasons someone may discuss alternatives with a healthcare provider include:

• A preference for a drug-free treatment format
• Medication side effects or interaction concerns
• A need for a different acute or preventive approach
• Insurance, cash-price, or access considerations
• A preference for a reusable at-home device
• The need to compare oral, nasal, injectable, and device-based options

No single treatment is appropriate for every person with migraine. A healthcare provider can help evaluate medical history, migraine pattern, current medications, pregnancy or breastfeeding status, and treatment goals.

1. Cefaly

Cefaly is a prescription-free, non-invasive neuromodulation option for adults seeking both acute and preventive migraine treatment in one reusable device. The original Cefaly device received FDA clearance for migraine prevention in 2014, and Cefaly Acute received clearance for acute treatment in 2017. Current Cefaly devices combine both treatment programs.

How Cefaly Works

Cefaly uses external trigeminal nerve stimulation, also called e-TNS. A self-adhesive electrode is placed on the forehead between and just above the eyebrows. The device sends controlled electrical impulses through the electrode to stimulate branches of the trigeminal nerve involved in migraine pain pathways.

The Cefaly mechanism differs from Nurtec’s medication-based CGRP receptor blockade. Cefaly is applied externally and does not involve systemic drug exposure.

Acute and Prevent Programs

Cefaly includes two treatment programs:

• Acute: A 60-minute session used during a migraine attack
• Prevent: A 20-minute session used daily for preventive treatment

Cefaly is FDA-cleared for acute treatment of migraine with or without aura and preventive treatment of migraine in patients 18 years of age or older.

Cefaly Clinical Evidence

Cefaly summarizes more than 20 years of research, more than 12 clinical trials, and three pivotal prospective, multicenter, sham-controlled randomized trials on its clinical studies page.

Key Cefaly-specific findings include the following:

• ACME study: 79% of participants experienced a significant reduction in headache pain after one hour of Cefaly Acute treatment. In addition, 63% reported that pain decreased by half or more.
• TEAM study: 56.4% of participants reported resolution of their most bothersome migraine symptom after two hours of treatment.
• PREMICE study: Participants who completed three months of compliant Prevent treatment experienced a 32.7% decrease in headache days.

The PREMICE study also reported a 74.4% decrease in acute migraine-medication intake among participants who responded to Prevent treatment. This result should not be interpreted as evidence that Cefaly has been established for medication-overuse headache. Cefaly labeling states that safety and effectiveness have not been demonstrated for patients with medication-overuse headache.

Safety and Contraindications

Cefaly clinical studies have reported no serious device-related adverse effects. Reported effects are generally minor and reversible and can include:

• Sleepiness during treatment
• Headache after a session
• Temporary forehead skin redness
• Nausea
• Forehead skin allergy or sensitivity

Do not use Cefaly if you have metallic or electronic devices implanted in your head, a cardiac pacemaker, or an implanted or wearable defibrillator. Cefaly is also not intended for pain of unknown origin.

Talk to a healthcare provider before using Cefaly if you are pregnant or may become pregnant, breastfeeding, have a complex medical history, are changing medications, have experienced a recent head injury or seizure, or have new or unusual headache symptoms. Cefaly is not a cure for migraine, and individual responses vary.

Practical Features

Cefaly differs from many migraine treatments through its combination of:

• Drug-free external stimulation
• Acute and preventive programs
• Prescription-free access in supported markets
• Reusable device ownership
• Forehead placement
• Rechargeable operation
• Optional app connectivity with Cefaly Connected

The Cefaly app can track treatments, attacks, symptoms, triggers, and selected wearable data. It can also generate reports to share with a healthcare provider. The app, Cefaly Connected device, and coaching services are not yet available in the EU.

Pricing, Electrodes, and Support

Cefaly’s current U.S. product page lists the device at $509. Replacement electrodes are the main recurring supply cost. Cefaly’s cost guide estimates approximately $350 to $450 per year for electrodes, depending on treatment frequency, electrode type, care, and storage.

Cefaly also offers:

• HSA/FSA eligibility for devices and electrodes, subject to plan rules
• Financing options through Affirm and PayPal where available
• An electrode subscription with 5% off and free shipping under current subscription terms
• Free one-on-one Cefaly Coach sessions where available
• A three-year limited product warranty for eligible devices purchased directly from Cefaly

If you are not satisfied with Cefaly, you can return the device for a refund within 90 calendar days of your product delivery date when purchased directly from the official website. Review the complete return policy for eligibility and conditions.

When Cefaly May Be Worth Discussing

Cefaly may be relevant to a treatment discussion when someone is comparing:

• Drug-free and medication-based options
• Acute and preventive treatment in one device
• Prescription-free and prescription-only access
• Reusable ownership and recurring prescription costs
• External forehead stimulation and oral, nasal, or injectable treatment formats

These are comparison factors, not individualized medical recommendations.

2. Other CGRP-Targeting Medications

People who want a medication in the same broad CGRP-targeting category as Nurtec may discuss other gepants or CGRP monoclonal antibodies with a healthcare provider.

Gepants

Ubrelvy (ubrogepant) is an oral CGRP receptor antagonist approved for the acute treatment of migraine with or without aura in adults. It is not indicated for preventive treatment. See the current Ubrelvy label.

Qulipta (atogepant) is an oral CGRP receptor antagonist indicated for preventive treatment of migraine in adults. It is taken daily rather than as an acute treatment. See the current Qulipta label.

Zavzpret (zavegepant) is a CGRP receptor antagonist nasal spray indicated for acute treatment of migraine with or without aura in adults. It is not indicated for prevention. See the current Zavzpret label.

CGRP Monoclonal Antibodies

Injectable CGRP-targeting preventive medications include:

• Aimovig (erenumab)
• Ajovy (fremanezumab)
• Emgality (galcanezumab)

These treatments require prescriptions and have product-specific dosing, contraindications, warnings, and insurance requirements. Their preventive-only format differs from Cefaly’s combined Acute and Prevent programs.

Main Comparison Points

When comparing CGRP medications with Cefaly, practical differences include:

• Prescription requirement
• Oral, nasal, or injectable administration
• Acute-only, preventive-only, or dual indication
• Drug interactions and systemic exposure
• Insurance coverage and recurring cost
• Device ownership versus repeat medication dispensing

3. Triptans for Acute Migraine Treatment

Triptans are prescription serotonin receptor agonists used for acute migraine treatment. Common examples include:

• Sumatriptan
• Rizatriptan
• Zolmitriptan
• Eletriptan
• Naratriptan
• Frovatriptan
• Almotriptan

Triptans are available in formulations that may include tablets, nasal sprays, and injections, depending on the medication. They are generally not used as preventive treatments.

Triptan labeling includes cardiovascular contraindications and warnings that vary by product. For example, sumatriptan is contraindicated in people with certain ischemic cardiovascular, cerebrovascular, peripheral vascular, and uncontrolled-hypertension conditions. Frequent use of acute medications can also contribute to medication-overuse headache.

Cefaly provides a different format because it is drug-free, prescription-free, and includes both acute and preventive programs. That difference does not make either approach universally appropriate for every person.

4. Over-the-Counter Pain Relievers

Some people use over-the-counter medications for acute migraine symptoms, including:

• Ibuprofen
• Naproxen sodium
• Aspirin
• Acetaminophen, aspirin, and caffeine combination products

These products differ from Nurtec and Cefaly because they are used for acute symptom relief rather than migraine prevention. They also carry product-specific warnings involving gastrointestinal bleeding, cardiovascular risk, kidney or liver conditions, pregnancy, drug interactions, and medication-overuse headache.

OTC availability does not mean a medication is appropriate for every person. Label directions and healthcare-provider guidance remain important, especially for frequent attacks, changing symptoms, pregnancy, complex medical history, or use of other medications.

5. Non-Pharmaceutical and Lifestyle Strategies

Non-pharmaceutical strategies can support a broader migraine treatment plan. They are not one single treatment category, and they should not be presented as substitutes for an indicated acute or preventive therapy.

Behavioral Approaches

Behavioral migraine care may include:

• Cognitive behavioral therapy
• Biofeedback
• Relaxation training
• Mindfulness-based practices

These approaches generally focus on coping skills, stress response, and behavioral patterns rather than directly replacing acute medication or neuromodulation.

Supplements

Magnesium, riboflavin, and coenzyme Q10 are frequently discussed in migraine prevention. Evidence, dosing, product quality, interactions, and suitability vary. The migraine supplements guide provides a high-level overview, but supplements should be discussed with a healthcare provider before use.

Cold Therapy and Sensory Reduction

During a migraine attack, some people use comfort measures such as:

• Resting in a dark, quiet room
• Applying a cool pack to the forehead or neck
• Reducing exposure to bright light, strong odors, or loud sound
• Limiting screen use when it worsens symptoms

These measures may improve comfort for some people but do not guarantee that an attack will stop.

Hydration, Meals, and Trigger Awareness

Regular hydration, consistent meals, adequate sleep, and awareness of individual triggers can support a migraine routine. Trigger patterns vary, and overly restrictive avoidance strategies can be difficult to sustain. A migraine tracker can help organize symptoms, treatments, and routine factors for discussion with a healthcare provider.

6. Other Neuromodulation Devices

Several FDA-cleared neuromodulation technologies are used for migraine. They differ in stimulation target, body placement, prescription status, treatment schedule, age indication, and payment model.

Remote Electrical Neuromodulation

Remote electrical neuromodulation devices are typically worn on the upper arm and controlled through a smartphone application. Current U.S. labeling for certain REN devices includes acute and preventive migraine treatment for specified pediatric and adult age groups and requires a prescription.

Non-Invasive Vagus Nerve Stimulation

Non-invasive vagus nerve stimulation devices are applied to the neck. Product labeling includes migraine and cluster-headache indications that vary by device and treatment program. These devices are prescription products.

Single-Pulse Transcranial Magnetic Stimulation

Single-pulse transcranial magnetic stimulation devices deliver magnetic pulses to the back of the head. Current migraine systems are prescription devices with product-specific acute and preventive indications.

How Cefaly Differs

Cefaly is not the only FDA-cleared or prescription-free migraine neuromodulation device. Its practical distinction is the combination of forehead-based e-TNS, Acute and Prevent programs for adults, prescription-free access, reusable ownership, and app-based tracking where available.

Readers comparing technologies can review Cefaly’s overview of migraine devices and confirm each product’s current FDA labeling before drawing conclusions.

Factors to Discuss With a Healthcare Provider

A healthcare provider can help compare Nurtec alternatives based on:

• Acute treatment needs
• Preventive treatment needs
• Migraine frequency and disability
• Aura and associated symptoms
• Current medications and interaction risks
• Cardiovascular, liver, kidney, or neurological history
• Pregnancy or breastfeeding
• Prior treatment response
• Preference for oral, nasal, injectable, or device-based treatment
• Insurance coverage and recurring cost

New, unusually severe, rapidly changing, or neurologically complex headaches require medical evaluation rather than self-directed treatment changes.

Getting Started With Cefaly

Cefaly’s getting started guide outlines the basic setup process:

1. Charge the device before first use. The initial charge takes about four hours.
2. Wash and dry the forehead so the electrode can adhere properly.
3. Position the electrode between and just above the eyebrows.
4. Attach the device magnetically to the electrode.
5. Select the Acute or Prevent program according to the device instructions.

Treatment intensity should be noticeable but not painful. Users can review the device manual, contact customer support, schedule a Cefaly Coach session, or locate certified providers for additional support.

Frequently Asked Questions

How does Cefaly compare with Nurtec?

Nurtec is a prescription oral CGRP receptor antagonist used for acute and preventive treatment in adults. Cefaly is a prescription-free external trigeminal nerve stimulation device used for acute and preventive migraine treatment in adults. Nurtec involves systemic drug exposure and product-specific interaction considerations. Cefaly is drug-free and does not create drug-drug interactions, but it can cause minor device-related effects and has device-specific contraindications.

What do Cefaly’s acute studies report?

In the ACME study, 79% of participants experienced a significant reduction in headache pain after one hour of Cefaly Acute treatment, and 63% reported that pain decreased by half or more. In the TEAM study, 56.4% reported resolution of their most bothersome migraine symptom after two hours. These are Cefaly-specific study results and should not be interpreted as direct comparisons with Nurtec or another treatment.

Can Cefaly be used for prevention?

Yes. Cefaly’s Prevent program is a 20-minute daily treatment. In the PREMICE study, participants who completed three months of compliant treatment experienced a 32.7% decrease in headache days.

Does Cefaly have side effects?

Reported effects are generally minor and reversible. They can include sleepiness, headache after a session, forehead redness, nausea, and rare forehead skin allergy or sensitivity. Cefaly should not be used with metallic or electronic head implants, a cardiac pacemaker, or an implanted or wearable defibrillator.

Is Cefaly HSA/FSA-eligible?

Cefaly devices and electrodes are listed as HSA/FSA-eligible expenses, subject to individual plan rules. Traditional insurance coverage varies, and Cefaly provides additional insurance information.

What is the difference between Cefaly Connected and Cefaly Enhanced?

Cefaly Connected adds Bluetooth connectivity and integration with the Cefaly app. Cefaly Enhanced provides Acute and Prevent programs without app connectivity. Current model availability and pricing vary by market and should be confirmed on the official website. The Cefaly app, Cefaly Connected device, and coaching services are not yet available in the EU.

Can Cefaly be used during pregnancy or breastfeeding?

Cefaly’s safety and effectiveness have not been specifically established in pregnant women. Anyone who is pregnant, may become pregnant, or is breastfeeding should discuss Cefaly and other migraine treatments with a healthcare provider before use.

Does Cefaly cure migraines?

No. Cefaly does not cure migraine or guarantee that every attack will stop. It is an FDA-cleared, drug-free treatment for acute migraine and migraine prevention in adults.